Skip Navigation LinksHome > July 2013 - Volume 35 - Issue 5 > Successful Treatment of Recurrent Pediatric Inflammatory Myo...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3182915cef
Clinical and Laboratory Observations

Successful Treatment of Recurrent Pediatric Inflammatory Myofibroblastic Tumor in a Single Patient With a Novel Chemotherapeutic Regimen Containing Celecoxib

Johnson, Kevin MD*; Notrica, David M. MD*,†,‡; Carpentieri, David MD§,∥,¶; Jaroszewski, Dawn MD#; Henry, Michael M. MD**

Collapse Box


Inflammatory myofibroblastic tumors are rare tumors characterized as low-to-intermediate grade sarcomas. This is a case of a 7-year-old male with a 5-cm lung mass, which recurred 11 months after complete resection. The recurrence manifested as multifocal metastatic disease involving the ipsilateral parietal and visceral pleura. A novel chemotherapeutic regimen, which included vincristine, ifosfamide, doxorubicin, and celecoxib was utilized for the disease recurrence. The patient had complete and durable remission of the disease and has been disease-free for >4 years. This novel regimen including a cyclooxygenase 2 inhibitor may be an effective regimen for metastatic inflammatory myofibroblastic tumors.

© 2013 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.